Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy.
Mo F, Duan S, Jiang X, Yang X, Hou X, Shi W, Carlos CJJ, Liu A, Yin S, Wang W, Yao H, Yu Z, Tang Z, Xie S, Ding Z, Zhao X, Hammock BD, Lu X.
Mo F, et al. Among authors: hammock bd.
Signal Transduct Target Ther. 2021 Feb 25;6(1):80. doi: 10.1038/s41392-021-00462-1.
Signal Transduct Target Ther. 2021.
PMID: 33627635
Free PMC article.